Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Abraxane Combined With Gemcitabine in the Patients With Metastatic Breast Cancer

NCT01550848 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01550848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Abraxane Combined With Gemcitabine in the Patients With Metastatic Breast Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2015
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer